97 related articles for article (PubMed ID: 33131967)
41. Differential expression of sphingolipids in MRP1 overexpressing HT29 cells.
Kok JW; Veldman RJ; Klappe K; Koning H; Filipeanu CM; Müller M
Int J Cancer; 2000 Jul; 87(2):172-8. PubMed ID: 10861470
[TBL] [Abstract][Full Text] [Related]
42. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
[TBL] [Abstract][Full Text] [Related]
43. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
44. Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma.
Mao ZP; Zhao LJ; Zhou SH; Liu MQ; Tan WF; Yao HT
Oncol Lett; 2015 Feb; 9(2):806-810. PubMed ID: 25621055
[TBL] [Abstract][Full Text] [Related]
45. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
46. Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold.
Galán-Malo P; Vela L; Gonzalo O; Calvo-Sanjuán R; Gracia-Fleta L; Naval J; Marzo I
Toxicol Appl Pharmacol; 2012 Feb; 258(3):384-93. PubMed ID: 22178383
[TBL] [Abstract][Full Text] [Related]
47. Reversal of P-gp and MRP1-mediated multidrug resistance by H6, a gypenoside aglycon from Gynostemma pentaphyllum, in vincristine-resistant human oral cancer (KB/VCR) cells.
Zhu H; Liu Z; Tang L; Liu J; Zhou M; Xie F; Wang Z; Wang Y; Shen S; Hu L; Yu L
Eur J Pharmacol; 2012 Dec; 696(1-3):43-53. PubMed ID: 23051672
[TBL] [Abstract][Full Text] [Related]
48. Dehydrothyrsiferol does not modulate multidrug resistance-associated protein 1 resistance: a functional screening system for MRP1 substrates.
Pec MK; Aguirre A; Fernández JJ; Souto ML; Dorta JF; Villar J
Int J Mol Med; 2002 Nov; 10(5):605-8. PubMed ID: 12373300
[TBL] [Abstract][Full Text] [Related]
49. Functional study of intracellular P-gp- and MRP1-mediated pumping of free cytosolic pirarubicin into acidic organelles in intrinsic resistant SiHa cells.
Laochariyakul P; Ponglikitmongkol M; Mankhetkorn S
Can J Physiol Pharmacol; 2003 Aug; 81(8):790-9. PubMed ID: 12897808
[TBL] [Abstract][Full Text] [Related]
50. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
Wu CH; Rastegar M; Gordon J; Safa AR
Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
[TBL] [Abstract][Full Text] [Related]
51. Caspase-3-dependent mitotic checkpoint inactivation by the small-molecule inducers of mitotic slippage SU6656 and geraldol.
Riffell JL; Jänicke RU; Roberge M
Mol Cancer Ther; 2011 May; 10(5):839-49. PubMed ID: 21441410
[TBL] [Abstract][Full Text] [Related]
52. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
[TBL] [Abstract][Full Text] [Related]
53. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
Zhang Q; Wang J; He H; Liu H; Yan X; Zou K
Phytother Res; 2014 Jul; 28(7):1037-44. PubMed ID: 25289403
[TBL] [Abstract][Full Text] [Related]
54. The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma.
Soini Y; Järvinen K; Kaarteenaho-Wiik R; Kinnula V
Ann Oncol; 2001 Sep; 12(9):1239-45. PubMed ID: 11697834
[TBL] [Abstract][Full Text] [Related]
55. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1.
Perrotton T; Trompier D; Chang XB; Di Pietro A; Baubichon-Cortay H
J Biol Chem; 2007 Oct; 282(43):31542-8. PubMed ID: 17646169
[TBL] [Abstract][Full Text] [Related]
56. Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo.
Meaden ER; Hoggard PG; Khoo SH; Back DJ
J Immunol Methods; 2002 Apr; 262(1-2):159-65. PubMed ID: 11983229
[TBL] [Abstract][Full Text] [Related]
57. Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport.
Hu K; Morris ME
J Pharm Sci; 2004 Jul; 93(7):1901-11. PubMed ID: 15176077
[TBL] [Abstract][Full Text] [Related]
58. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
He SM; Li R; Kanwar JR; Zhou SF
Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of spindle elongation by taxol.
Amin-Hanjani S; Wadsworth P
Cell Motil Cytoskeleton; 1991; 20(2):136-44. PubMed ID: 1684311
[TBL] [Abstract][Full Text] [Related]
60. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells.
Ibrado AM; Kim CN; Bhalla K
Leukemia; 1998 Dec; 12(12):1930-6. PubMed ID: 9844922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
